EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of precision medicine on different endotypes of asthma

Nadia Muzaffar, Muhammad Baber, Hafiza Iqra Malik

Exploration of Asthma & Allergy · 2025

DOI: 10.37349/eaa.2025.100984 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Asthma & Allergy, 2025. Verfasst von Nadia Muzaffar und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over 330 million people globally have asthma, a chronic disease with multiple endotypes and observable phenotypes. This disease has a substantial socioeconomic impact. A thorough assessment of multiple clinical aspects (such as the presence of atopy, comorbidities, and clinical presentations), characteristics of lung function (such as the degree of bronchial reversibility, the involvement of the airway obstruction, and airway hyperreactivity), and the interaction of sputum and systemic inflammatory factors (such as neutrophilic, eosinophilic, and mixed) are required to determine the specific endotypes of asthma. The precision medicine approach to asthma represents a new paradigm, with improved opportunities for more effective and appropriate personalized therapies and new insights into the immunological aspects of asthma that demand further research. In the world of precision medicine, biomarker-based therapies for individual patients are just the beginning of an exciting and emerging journey in allergy treatment. A collection of biomarkers might be utilized to define and classify the endotypes based on the phenotyping of asthma, which will be more likely with omics information and unbiased clustering. This review will contribute to the development of personalized therapy for asthma, enabling more accurate treatment. It will also serve as a source of novel targets and new treatments for every identified endotype.

Zitieren

APA

Muzaffar, N., Baber, M., & Malik, H. I. (2025). Role of precision medicine on different endotypes of asthma. Exploration of Asthma & Allergy. https://doi.org/10.37349/eaa.2025.100984

Vancouver

Muzaffar N, Baber M, Malik HI. Role of precision medicine on different endotypes of asthma. Exploration of Asthma & Allergy. 2025. doi:10.37349/eaa.2025.100984

BibTeX
@article{Muzaffar2025,
  author = {Muzaffar, Nadia and Baber, Muhammad and Malik, Hafiza Iqra},
  title = {Role of precision medicine on different endotypes of asthma},
  journal = {Exploration of Asthma & Allergy},
  year = {2025},
  doi = {10.37349/eaa.2025.100984}
}
Kostenlos starten →